Search results
Mounjaro vs. Ozempic: Which Is Better for Weight Loss?
MediaFeed via AOL· 4 days agoIn one corner, we’ve got Mounjaro, and in the other, Ozempic. They’re both once-a-week injectable...
Roche To Ride Booming Obesity Treatment Market With Newly-Acquired Drug Candidate
Benzinga via Yahoo Finance· 7 hours agoThe study found that a once-weekly subcutaneous injection of CT-388 over 24 weeks resulted in...
Valleant Launched A New Article About The Proven Techniques to Treat Diabetes
Digital Journal· 5 hours agoValeant's commitment to advancing diabetes treatment is underscored by its ongoing investment in research and development. The...innovative therapies to ...
Eli Lilly says its experimental weekly insulin works just as well as daily doses
Quartz· 7 hours agoEli Lilly announced positive result on Thursday of its phase-3 clinical trails (QWINT-2 and QWINT-4)...
What we know about the weight loss drug Ozempic
Yahoo News UK· 2 days agoWhat we know Semaglutide, the drug contained in Ozempic jabs, was first developed in 2012 and first approved for use in 2017 in the US and 2019 in the...
Long-Term Effects of Weight-Loss Drugs Revealed in Groundbreaking New Study
Best Life· 2 days agoCritics of weight-loss drugs insist they're too good to be true. A new study is illustrating the...
Roche (RHHBY) Posts Encouraging Phase I Obesity Drug Data
Zacks via Yahoo Finance· 12 hours agoData from the study shows that nearly half of the patients who received Roche's (RHHBY)...
59-year-old Man Who Had Type 2 Diabetes for 25 Years is Cured by Stem Cells
GoodNewsNetwork· 4 days agoStem cells are being used more and more widely in treatments across the spectrum of medicine, but a...
Ozempic maker Novo Nordisk says it will study drug’s effects on alcohol consumption but isn’t...
CNN via Yahoo Finance· 8 hours agoThe company plans to start assessing the effects of semaglutide, the active ingredient in Ozempic,...
UPDATE 2-Lilly's weekly insulin as effective as daily doses in studies
Reuters via Yahoo Finance· 14 hours agoEli Lilly said on Thursday its once-weekly insulin injection, efsitora, showed blood sugar reduction that was consistent with commonly used daily insulins across two studies in patients with ...